The first order of business was to develop a business plan, which will be completed by the end of August. This plan is concentrated around the following focus areas:
Human Development and Aging Cancer Cardiovascular Diseases Neurological Diseases Infectious Diseases Plans for commercialization, economic development, and educational support will be included. Our goal is to develop a ten-year investment strategy that will enable the Area's research institutions to collectively attain $500 million annually in Research and Development expenditures.
How do we determine Kansas City's niche? The competition is considerable and we will not be able to compete in every field. In order to make the best possible investment decisions, we are employing the following: an external Scientific Advisory Committee and a process called "business dynamics modeling." The Committee will advise us on the science and where they believe we can be competitive. The business dynamics modeling will show us what it will take to achieve the goal of $500 million in annual R & D expenditures.
The business plan will be presented to the boards of directors of the Kansas City Area Development Council and the Civic Council of Greater Kansas City for approval on September 8, 2000. Fund raising will begin shortly thereafter.
